I find it a little strange that no-one has talked about what is missing from the announcement yet. First remember that "The highest impact journals have a policy of not publishing papers where the data has been previously released in any form." While I assume that there are some additional measures of cardio-protection that will provide further insight into this aspect of the opportunity, something larger is missing.
There has been zero information given regarding the efficacy of the combination in killing cancer cells... Is this what we will have to wait until publication for?
I am generally quite a reserved investor, but this sounds... large. I also note that the language in this announcement is different to all of our other positive results, almost giddy. I look forward to the paper being released.
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-93
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |